CenterBook Partners
RVMD icon

CenterBook Partners’s Revolution Medicines RVMD Stock Holding History

CenterBook Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.53M Buy
+7,460
New +$1.48M 0.07% 346
2026
Q2 		– Sell
-5,769
Closed -$561K – 849
2026
Q1 		$561K Buy
+5,769
New +$583K 0.03% 466

Other funds holding RVMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

CenterBook Partners's RVMD Position: Q3 2026 in Review

CenterBook Partners opened a new position in Revolution Medicines (RVMD) in Q3 2026: 7,460 shares worth $1.53M. The stake represents 0.07% of the portfolio and ranks #346 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in RVMD as recently as Q1 2026.

CenterBook Partners first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • CenterBook Partners held 7,460 shares of Revolution Medicines worth $1.53M as of Q3 2026.
  • Revolution Medicines was a new CenterBook Partners position in Q3 2026.
  • Revolution Medicines made up 0.07% of CenterBook Partners's portfolio in Q3 2026, its #346 holding.
  • CenterBook Partners first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 329 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.